Quality of control arms in randomized clinical trial implies also optimal postprotocol treatment.
The need for optimal crossover in trials testing the anticipation of treatments: A methodological and ethical issue
Di Maio, Massimo
First
2024-01-01
Abstract
Quality of control arms in randomized clinical trial implies also optimal postprotocol treatment.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Editorial Desai Cancer 2024 revised.docx
Accesso riservato
Descrizione: Submitted paper
Tipo di file:
PREPRINT (PRIMA BOZZA)
Dimensione
29.99 kB
Formato
Microsoft Word XML
|
29.99 kB | Microsoft Word XML | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
